Luigina Mollica

Montreal, QC H1T2M4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Journal: Open forum infectious diseases

Published: December 23, 2025

MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.

MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.

Journal: Blood advances

Published: October 08, 2025

From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation.

From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation.

Journal: Current oncology (Toronto, Ont.)

Published: August 26, 2025

Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center.

Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center.

Journal: Current oncology (Toronto, Ont.)

Published: March 24, 2025

Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience.

Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience.

Journal: Current oncology (Toronto, Ont.)

Published: January 05, 2025

Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case report.

Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case report.

Journal: Transfusion

Published: November 13, 2024

Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.

Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.

Journal: Blood cancer journal

Published: November 11, 2024

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group.

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group.

Journal: Blood cancer journal

Published: October 06, 2024

Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals.

Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals.

Journal: Blood advances

Published: August 26, 2022

Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.

Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.

Journal: Transplantation and cellular therapy

Published: July 03, 2022

Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.

Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.

Journal: Transplantation and cellular therapy

Published: March 27, 2021

Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group.

Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group.

Journal: American journal of hematology

Published: March 07, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026